ACADIAN ASSET MANAGEMENT LLC - HTG MOLECULAR DIAGNOSTICS IN ownership

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of HTG MOLECULAR DIAGNOSTICS IN
ValueSharesWeighting
Q1 2019$49,000
-91.5%
19,622
-91.4%
0.00%
-100.0%
Q4 2018$577,000
+26.8%
227,407
+152.3%
0.00%
+50.0%
Q3 2018$455,000
+28.9%
90,131
-16.8%
0.00%0.0%
Q2 2018$353,000108,2870.00%
Other shareholders
HTG MOLECULAR DIAGNOSTICS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Novo Holdings A/S 1,280,185$9,755,0001.01%
Cormorant Asset Management, LP 201,000$1,532,0000.24%
PUTNAM INVESTMENTS LLC 575,692$4,386,0000.01%
Alyeska Investment Group, L.P. 114,113$870,0000.01%
VANGUARD GROUP INC 4,355,424$131,473,0000.01%
BLACKROCK ADVISORS LLC 463,200$3,530,0000.00%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 26,100$199,000,0000.00%
Ironwood Financial, llc 870$7,0000.00%
PANAGORA ASSET MANAGEMENT INC 24,293$185,0000.00%
Sonora Investment Management, LLC 500$3,0000.00%
View complete list of HTG MOLECULAR DIAGNOSTICS IN shareholders